John Hoeven sold CDK Global, Inc. (NASDAQ) (CDK)
John Hoeven (R-ND), a U.S. Senator, has disclosed 1 trade in CDK Global, Inc. (NASDAQ) (CDK) since 2014, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: John Hoeven sold $15,001 - $50,000 of CDK Global, Inc. (NASDAQ) (CDK) on October 1, 2014. Since that trade, CDK is up +0.00% against the S&P 500 up +355.73%, an outperformance of -355.73%.
Data updated
John Hoeven's CDK trades vs the price
CDK is up +0.00% since John Hoeven sold on October 1, 2014, versus +355.73% for the S&P 500.
Performance since this trade
All John Hoeven CDK trades
John Hoeven & CDK trading FAQ
Is it legal for John Hoeven to trade CDK Global, Inc. (NASDAQ) (CDK) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CDK Global, Inc. (NASDAQ) (CDK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John Hoeven sell CDK?
John Hoeven disclosed a sale of $15,001 - $50,000 of CDK Global, Inc. (NASDAQ) (CDK) on October 1, 2014, according to public STOCK Act filings.
How has CDK performed since John Hoeven's trade?
Since John Hoeven sold CDK on October 1, 2014, the stock is up +0.00%, versus +355.73% for the S&P 500 over the same period, an outperformance of -355.73%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CDK trades?
Quantellect tracks every disclosed congressional trade in CDK Global, Inc. (NASDAQ) (CDK) on the CDK Global, Inc. (NASDAQ) congressional trading page, which aggregates filings across all members of Congress.
John Hoeven's CDK tradesAll congressional filings for CDK Global, Inc. (NASDAQ)John Hoeven's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.